Endocrine Society announces departure of CEO, Barbara Byrd Keenan

The Endocrine Society has announced the departure of CEO Barbara Byrd Keenan, FASAE, CAE, effective February 5, 2020. Keenan had served in the role since 2014.

“Under Barbara’s leadership, we’ve expanded the reach and influence of the Endocrine Society, and experienced growth and increased engagement of our staff, Board, and members,” said Endocrine Society President E. Dale Abel, M.D., Ph.D., of the University of Iowa, Carver College of Medicine, Iowa City, Iowa. “On behalf of the Board, we extend our appreciation to Barbara for her years of service and wish her well in her future endeavors.”

Under Keenan’s leadership the Society accelerated its global engagement, repositioned its suite of publications, implemented a new strategic plan, and forged many new strategic partnerships. In the past six years the Society won 10 awards for education, finance, program development, communications and diversity.

“Barbara has left us well positioned for continued growth,” said Abel, “and we are looking forward to expanding our role as the world’s leading endocrine society.”

The Endocrine Society Board of Directors will engage in a formal search process for a Chief Executive Officer.

About Endocrine Society

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.